Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $4.86 in the last session, down -8.38% from day before closing price of $5.31. In other words, the price has decreased by -$8.38 from its previous closing price. On the day, 0.52 million shares were traded. ORIC stock price reached its highest trading level at $5.3 during the session, while it also had its lowest trading level at $4.76.
Ratios:
We take a closer look at ORIC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.00 and its Current Ratio is at 12.00. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on October 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $20.
On September 06, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 16 ’24 when Piscitelli Dominic sold 8,851 shares for $8.28 per share. The transaction valued at 73,298 led to the insider holds 106,764 shares of the business.
Multani Pratik S sold 8,850 shares of ORIC for $73,293 on Dec 16 ’24. The Chief Medical Officer now owns 46,765 shares after completing the transaction at $8.28 per share. On Dec 16 ’24, another insider, Chacko Jacob, who serves as the PRESIDENT AND CEO of the company, sold 24,660 shares for $8.28 each. As a result, the insider received 204,214 and left with 778,648 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 345843584 and an Enterprise Value of 150836512.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.30, which has changed by -0.460643 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.67, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is -18.00%, while the 200-Day Moving Average is calculated to be -43.35%.
Shares Statistics:
According to the various share statistics, ORIC traded on average about 830.27K shares per day over the past 3-months and 596010 shares per day over the past 10 days. A total of 71.08M shares are outstanding, with a floating share count of 43.03M. Insiders hold about 39.48% of the company’s shares, while institutions hold 72.50% stake in the company. Shares short for ORIC as of 1745971200 were 11192498 with a Short Ratio of 13.48, compared to 1743379200 on 15102133. Therefore, it implies a Short% of Shares Outstanding of 11192498 and a Short% of Float of 16.02.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Its stock is currently analyzed by 8.0 different market analysts. The consensus estimate for the next quarter is -$0.47, with high estimates of -$0.39 and low estimates of -$0.53.
Analysts are recommending an EPS of between -$1.51 and -$2.02 for the fiscal current year, implying an average EPS of -$1.81. EPS for the following year is -$1.8, with 10.0 analysts recommending between -$1.47 and -$2.18.
